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1. Introduction 
Protein engineering is the design of new enzymes or proteins with new or desirable 
functions. It is based on the use of recombinant DNA technology to change amino acid 
sequences. The first papers on protein engineering date back to early 1980ies: in a review by 
Ulmer (1983), the prospects for protein engineering, such as X-ray crystallography, chemical 
DNA synthesis, computer modelling of protein structure and folding were discussed and 
the combination of crystal structure and protein chemistry information with artificial gene 
synthesis was emphasized as a powerful approach to obtain proteins with desirable 
properties (Ulmer, 1983). In a later review in 1992, protein engineering was mentioned as a 
highly promising technique within the frame of biocatalyst engineering to improve enzyme 
stability and efficiency in low water systems (Gupta, 1992). Today, owing to the 
development in recombinant DNA technology and high-throughput screening techniques, 
protein engineering methods and applications are becoming increasingly important and 
widespread. In this Chapter, a chronological review of protein engineering methods and 
applications is provided. 
2. Protein engineering methods 
Many different protein engineering methods are available today, owing to the rapid 
development in biological sciences, more specifically, recombinant DNA technology. These 
methods are chronologically reviewed in this section, and summarized in Table 1.  
The most classical method in protein engineering is the so-called “rational design” approach 
which involves “site-directed mutagenesis” of proteins (Arnold, 1993). Site-directed 
mutagenesis allows introduction of specific amino acids into a target gene. There are two 
common methods for site-directed mutagenesis. One is called the “overlap extension” 
method. This method involves two primer pairs, where one primer of each primer pair 
contains the mutant codon with a mismatched sequence. These four primers are used in the 
first polymerase chain reaction (PCR), where two PCRs take place, and two double-stranded 
DNA products are obtained. Upon denaturation and annealing of them, two heteroduplexes 
are formed, and each strand of the heteroduplex involves the desired mutagenic codon. 
DNA polymerase is then used to fill in the overlapping 3’ and 5’ ends of each heteroduplex 
and the second PCR takes place using the nonmutated primer set to amplify the mutagenic 
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DNA. The other site-directed mutagenesis method is called “whole plasmid single round 
PCR”. This method forms the basis of the commercial “QuikChange Site-Directed 
Mutagenesis Kit” from Stratagene. It requires two oligonucleotide primers with the desired 
mutation(s) which are complementary to the opposite strands of a double-stranded DNA 
plasmid template. Using DNA polymerase PCR takes place, and both strands of the 
template are replicated without displacing the primers and a mutated plasmid is obtained 
with breaks that do not overlap. DpnI methylase is then used for selective digestion to 
obtain a circular, nicked vector with the mutant gene. Upon transformation of the nicked 
vector into competent cells, the nick in the DNA is repaired, and a circular, mutated plasmid 
is obtained (Antikainen & Martin, 2005). 
Rational design is an effective approach when the structure and mechanism of the protein of 
interest are well-known. In many cases of protein engineering, however, there is limited 
amount of information on the structure and mechanisms of the protein of interest. Thus, the 
use of “evolutionary methods” that involve “random mutagenesis and selection” for the 
desired protein properties was introduced as an alternative approach. Application of 
random mutagenesis could be an effective method, particularly when there is limited 
information on protein structure and mechanism. The only requirement here is the 
availability of a suitable selection scheme that favours the desired protein properties 
(Arnold, 1993). A simple and common technique for random mutagenesis is “saturation 
mutagenesis”. It involves the replacement of a single amino acid within a protein with each 
of the natural amino acids, and provides all possible variations at that site. “Localized or 
region-specific random mutagenesis” is another technique which is a combination of 
rational and random approaches of protein engineering. It includes the simultaneous 
replacement of a few amino acid residues in a specific region, to obtain proteins with new 
specificities. This technique also makes use of overlap extension, and the whole-plasmid, 
single round PCR mutagenesis, as in the case of site-directed mutagenesis. However, the 
major difference here is that the codons for the selected amino acids are randomized, such 
that a mixture of 64 different forward and 64 different reverse primers are used, based on a 
statistical mixture of four bases and three nucleotides in a randomized codon (Antikainen & 
Martin, 2005). 
In 1994, important fields for protein engineering were also discussed in a review article by 
Anthonsen and co-workers (Anthonsen et al., 1994). The challenge in protein sequence 
deduction from DNA sequence, resulting from post-transcriptional and post-translational 
modifications and splicing, was emphasized. Homology modelling of protein structures, 
NMR of large proteins, molecular dynamics simulations of protein structures, and 
simulation of electrostatic effects (such as pH-dependent effects) were mentioned as 
important scientific areas to provide additional key information to protein engineering 
studies.  
Another important method that finds applications in protein engineering is 
“peptidomimetics”. It involves mimicking or blocking the activity of enzymes or natural 
peptides upon design and synthesis of peptide analogs that are metabolically stable. 
Peptidomimetics is an important approach for bioorganic and medical chemistry. It includes 
a variety of synthesis methods such as the use of a common intermediate, solid phase 
synthesis and combinatorial approaches (Venkatesan & Kim, 2002).  
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 “In vitro protein evolution systems” are also important methods in protein engineering. 
They are based on the hierarchical evolution principle of genes. It was suggested that 
modern genes developed from small genetic units upon hierarchical and combinatorial 
processes. An example is MolCraft, an in silico evolved microgene which was then tandemly 
polymerized, including insertion or deletion mutations at the junctions between microgene 
units. The junctional perturbations allowed molecular diversity and the formation of 
combinatorial peptide polymers, whereas the repetitiousness allowed the formation of 
ordered structures (Shiba, 2004).  
In a review article by Antikainen and Martin, (2005), the major protein engineering methods 
were described in detail. These methods were classified as rational methods that involve 
site-directed mutagenesis, random methods including random mutagenesis and 
evolutionary methods which involve “DNA shuffling”. In DNA shuffling method, a group 
of genes with a double-stranded DNA and similar sequences is obtained from various 
organisms or produced by error-prone PCR. Digestion of these genes with DNaseI yields 
randomly cleaved small fragments, which are purified and reassembled by PCR, using an 
error-prone and thermostable DNA polymerase. The fragments themselves are used as PCR 
primers, which align and cross-prime each other. Thus, a hybrid DNA with parts from 
different parent genes is obtained. Variations of DNA shuffling method such as the use of a 
mixture of restriction endonucleases instead of DNaseI, or the “staggered extension process” 
that does not require parental gene fragmentation were also discussed (Antikainen & 
Martin, 2005). Additionally, the development of efficient screening methods to screen large 
libraries of proteins/enzymes such as “cell surface libraries coupled with fluorescence 
activated cell sorting (FACS)”, or “phage display technology” were discussed (Antikainen & 
Martin, 2005). The combination of cell surface libraries with FACS can be used to screen 
very large libraries. The system is based on a scissile bond of the substrate, such as an Arg-
Val linkage, which can be cleaved by a surface-displayed enzyme or not. The scissile bond 
on the designed substrate links a fluorophore and a quencher. If the scissile bond of the 
substrate is not cleaved by the surface-displayed enzyme, the fluorophore emission is then 
quenched by the quenching fluorophore. Thus, no fluorescence emission occurs. However, 
if the enzyme cleaves the scissile bond of the substrate, the fluorophore and the quenching 
fluorophore are then separated, and fluorescence occurs. Fluorescence of the clones with 
cleavage of the scissile bond is then detected by FACS (Antikainen & Martin, 2005). Phage 
display technology is another powerful technique for screening large libraries of proteins. 
The method requires degenerate reverse primers to be used in a PCR for random 
mutagenesis of the starting cDNA throughout a target region. The PCR products are then 
subcloned into a bacteriophage vector coding for a phage coat protein. Each phage of the 
mutant pool expresses a different protein displayed on the coat protein of the phage surface. 
Elution experiments help screen and identify the variants that bind tightly to a substrate of 
interest. Thus, the identified mutants are purified and sequenced (Antikainen & Martin, 
2005). 
“Flow cytometry”, a powerful method for single cell analysis, is also used in protein 
engineering studies. A variety of examples are available where the sorting was done 
according to ligand binding in antibody and peptide surface display studies, or enzyme 
engineering of intra- and extracellular enzymes (Mattanovich & Borth, 2006). 
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The advantages and disadvantages of random mutagenesis methods used in protein 
engineering were also determined and compared to each other in detail. Based on the 
nucleotide substitution method used, these random mutagenesis methods were divided into 
four major groups: enzyme-based methods, synthetic chemistry-based methods, whole cell 
methods and combined methods. Their comparison was made according to a variety of 
parameters such as controllable mutation frequency, technical robustness, cost-effectiveness, 
etc. (Wong et al., 2006). 
 “Cell-free translation systems” were also described as important tools for protein 
engineering and production. They are an alternative to in vivo protein expression. When 
template DNA or mRNA is added to a reaction mixture, proteins are produced upon 
incubation in the absence of cells. PCR products can be used, and proteins are synthesized 
from cDNA rapidly. Cell-free translation systems are based on the ribosomal protein system 
of cells, which is provided as a cell extract from Escherichia coli etc. obtained as a supernatant 
upon centrifugation at 30’000 g. This supernatant contains necessary compounds for protein 
synthesis, such as ribosomes, t-RNAs, translation factors and aminoacyl-tRNA synthetases. 
Potential applications involve production of biologically active proteins, synthesis of 
membrane proteins for minimal cells, and artificial proteins. With further development, cell-
free translation systems could be a strong alternative to in vivo protein expression, due to 
their high level of controllability and simplicity. The limitations of recombinant protein 
expression in living cells, such as protein degradation and aggregation will also be avoided 
(Shimizu et al., 2006). 
Green fluorescent protein (GFP) is a very important protein that is widely used for 
biological and medical research purposes. It is a 238-residue protein from the jellyfish 
Aequorea victoria. GFP has unique spectroscopic characteristics, undergoes an autocatalytic 
post-translational cyclization and oxidation of the polypeptide chain around Ser65, Tyr66, 
and Gly67 residues, to form an extended and rigidly encapsulated conjugated Π system, the 
chromophore, that emits green fluorescence. Additionally, no cofactors are required for the 
formation or the function of the chromophore. GFP has high structural stability and high 
fluorescence quantum yield, which are other important properties for its widespread use. 
GFP has been modified extensively to be used as a marker for gene expression, protein 
localization and protein-protein interactions, as well as a biosensor. The proper folding of 
GFP is critical for its functional efficiency. Thus, protein engineering methods such as 
random mutagenesis and screening, DNA shuffling, as well as computational methods and 
X-ray crystallography improved the folding of GFP and emphasized the importance of the 
use of different methods such as biophysical techniques in improving protein properties 
(Jackson et al., 2006). 
 “Designed divergent evolution” is also an important protein engineering method that is 
used in redesigning enzyme function. The method is based on the theories of divergent 
molecular evolution. According to these theories, firstly, enzymes with more specialized and 
active functions have evolved from those enzymes with promiscuous functions. Secondly, 
this process is driven by a few amino acid substitutions; and finally, the effects of 
double/multiple mutations are usually additive. Thus, the method allows the selection of 
combinations of mutations that would confer the desired functions and their introduction 
into the enzymes (Yoshikuni & Keasling, 2007).  
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 “Stimulus-responsive peptide systems” are based on both naturally existing peptides and 
rationally engineered systems. These systems exploit the fact that the peptides and proteins 
are able to change their conformations as a response to external stimulants such as pH, 
temperature or some specific molecules. There is a broad range of applications of these 
systems in research fields such as biosensors, bioseparations, drug delivery, nanodevices 
and tissue engineering. Directed evolution of stimulus-responsive peptides, however, 
requires an appropriate selection or screening scheme. Thus, protein-based conformational 
change sensors (CCSs) were developed using immunofluorescence and recombinant DNA 
technology (Chockalingam et al., 2007).  
Avidin and streptavidin are proteins that are structurally and functionally analogous. 
Because of their ability to bind biotin very tightly, they are widely used in (strept)avidin-
biotin binding technology that is a common tool in life sciences and nanotechnology. To 
further improve these protein tools and obtain genetically engineered (strept)avidins, 
protein engineering methods were applied including simple amino acid substitutions to 
change physico-chemical properties, or more complex changes, such as chimeric 
(strept)avidins, topology rearrangements and non-natural amino acid stitching into the 
active sites (Laitinen et al., 2007). 
 “Receptor-based QSAR methods” are also valuable for protein engineering studies. These 
methods are based on a computational combination of structure-activity relationship 
analysis and receptor structure-based design. They provide valuable pharmacological 
information on therapeutic targets. The Comparative Binding Energy (COMBINE) analysis, 
for example, probes bioactivity changes with respect to amino acid variations in a series of 
homologous protein receptors and with respect to conformational changes within a protein 
of interest (Lushington et al., 2007). 
As mentioned previously, phage display technology is one of the most commonly known 
molecular display technologies which relates phenotypes with their corresponding 
genotypes. Phage display technique is used particularly in “synthetic binding protein 
engineering”, where libraries of ‘synthetic’ binding proteins were developed with antigen-
binding sites constructed from man-made diversity. It was suggested that the combination 
of phage display and synthetic combinatorial libraries will be preferred for synthetic 
binding protein engineering (Sidhu & Koide, 2007). Similar to phage display technology, 
“yeast surface display” is also a useful method for protein engineering and characterization. 
Using this method, many different proteins can be displayed on yeast surface, and the yeast 
secretory biosynthetic system promotes efficient N-linked glycosylation and oxidative 
protein folding. Rapid and quantitative library screening by FACS analysis and easy 
characterization of mutants without requiring their soluble expression and purification are 
among the major advantages of this method. Yeast surface display has recently been 
suggested as an important methodology for protein characterization, and identifying 
protein-protein interactions (Gai & Wittrup, 2007). In a later review article, library creation 
methods and display technologies related with enzyme evolution and protein engineering 
were also discussed in detail (Chaput et al., 2008). 
An interesting protein tool that was obtained by protein engineering methods is “anticalin”. 
It offers a variety of applications in biochemical research as well as in medical therapy as 
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potential drugs. Anticalins are a combination of antibodies and lipocalins. Lipocalins are a 
protein family with a binding site that has high structural plasticity. By applying protein 
engineering methods such as site-directed random mutagenesis and selection by phage 
display technology, artificial lipocalins with novel ligand specificities, i.e. “anticalins” were 
obtained. Anticalins have many advantages such as being significantly smaller than 
antibodies, not requiring post-translational modifications, having robust biophysical 
properties and the ability to be produced in microbial expression systems (Skerra, 2008).  
Method name Reference(s) 
Rational design (Arnold, 1993) 
Site-directed mutagenesis (Arnold, 1993), (Antikainen & Martin, 2005) 
Evolutionary methods/directed 
evolution 
(Arnold, 1993) 
Random mutagenesis (Antikainen & Martin, 2005), (Wong et al., 2006), 
(Jackson et al., 2006), (Labrou, 2010) 
DNA shuffling (Antikainen & Martin, 2005), (Jackson et al., 2006) 
Molecular dynamics (Anthonsen et al., 1994) 
Homology modeling (Anthonsen et al., 1994) 
‘MolCraft‘in vitro protein evolution 
systems 
(Shiba, 2004) 
Computational methods 
(computational protein design) 
(Jackson et al., 2006), (Van der Sloot et al., 2009), 
(Golynskiy & Seelig, 2010) 
Receptor-based QSAR methods (Lushington et al., 2007) 
NMR (Anthonsen et al., 1994) 
X-ray crystallography (Jackson et al., 2006) 
Peptidomimetics (Venkatesan & Kim, 2002) 
Phage display technology (Antikainen & Martin, 2005), (Sidhu & Koide, 
2007), (Chaput et al., 2008) 
Cell surface display technology (Antikainen & Martin, 2005), (Gai & Wittrup, 2007), 
(Chaput et al., 2008) 
Flow cytometry / Cell sorting (Mattanovich & Borth, 2006 ) 
Cell-free translation systems (Shimizu et al., 2006) 
Designed divergent evolution (Yoshikuni & Keasling, 2007) 
Stimulus-responsive peptide systems (Chockalingam et al., 2007) 
Mechanical engineering of 
elastomeric proteins 
(Li, 2008) 
Engineering extracellular matrix 
variants 
(Carson & Barker, 2009) 
Traceless Staudinger ligation (Tam & Raines, 2009) 
De novo enzyme engineering (Golynskiy & Seelig, 2010) 
mRNA display (Golynskiy & Seelig, 2010) 
Table 1. A summary of different methods used in protein engineering 
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In a recent review by Goodey and Benkovic (2008), the allosteric regulation of proteins was 
discussed in detail. Ligand binding or an amino acid mutation at an allosteric site can 
significantly change enzymatic activity or binding affinity at another site such as the active 
site. Thus, this site-to-site communication of allosteric regulation is an important concept to 
be considered for protein engineering studies. Particularly, if the allosteric mechanisms are 
well understood, new proteins with switch-like properties could be designed for drug 
delivery, etc. (Goodey & Benkovic, 2008).  
Recently, engineering of elastomeric proteins has been discussed as a new approach to 
improve the mechanical properties for the construction of biomaterials. Elastomeric proteins 
are important in regulating the mechanical properties in biological machineries. Using a 
combination of protein engineering methods and single molecule atomic force microscopy, 
the molecular basis of the mechanical stability of elastomeric proteins could be understood, 
and the mechanical properties of elastomeric proteins could be further improved by their 
‘mechanical engineering’ (Li, 2008).  
Protein and catalytic promiscuity are also important concepts for protein engineering. 
Catalytic promiscuity is defined as the ability of a single active site to catalyse more than one 
chemical reaction (Kazlauskas, 2005). Understanding protein and catalytic promiscuity is 
important for optimizing protein engineering applications (Nobeli et al., 2009). 
In a recent review, the advances in mammalian cell and protein evolution were discussed, 
which would have important applications in commercial mammalian cell biotechnology. As 
mutagenesis and selection of mammalian cells is quite elaborate, the improvement of 
mammalian protein evolution systems would be crucial for obtaining new diagnostic tools 
and designer polypeptides (Majors et al., 2009).   
Another recent concept in protein engineering research is the “engineering of extracellular 
matrix variants” to direct cell behaviour, particularly differentiation, as a response to 
biomaterials, in regenerative medicine applications. Extracellular matrix-derived peptides, 
such as Arg-Gly-Asp, are useful in supporting cell adhesion and specific integrin-signalling 
scaffolds and growth factor-receptor signalling are required for directing cell phenotype. 
Thus, by making use of this information, engineering of extracellular matrix variants could 
be a promising protein engineering approach (Carson & Barker, 2009). 
Manipulation of proteins in a controlled way is a key requirement for many protein 
engineering studies. To facilitate that, “the traceless Staudinger ligation” method was 
recently introduced. It is based on the Staudinger reaction, where a phosphine is used to 
reduce an azide to an amide. The reaction occurs by means of a stable intermediate, an 
iminophosphorane, that has a nucleophilic nitrogen which can be acylated in inter- and 
intramolecular ligations. In peptide synthesis, the Staudinger reaction is applied by using a 
phosphinothiol for uniting an azide and a thioester. This method allows convergent 
chemical synthesis of proteins, and can ligate peptides at noncysteine residues. Thus, it 
overcomes a limitation of other strategies, and can be used as a powerful method for protein 
engineering (Tam & Raines, 2009). 
In addition to the traditional methods of protein engineering, such as ‘classical’ rational 
design and directed-evolution methods, computational protein design tools are becoming 
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increasingly important. In a recent review by Van der Sloot et al. (2009), “computational 
protein design principles and applications” were discussed. Computational protein design 
principles are based on the combination of a force field and a search algorithm to identify 
the amino acid sequence that is most compatible with a given protein three-dimensional 
backbone structure. At selected positions, the computational protein design algorithm 
‘mutates’ or changes the original amino acid to all other natural amino acids and results in 
new conformations. The energy of the structure is determined after simultaneous 
optimization of the side-chain and/or backbone conformations of the substituted  amino 
acid and the interacting amino acids. Thus, low energy substitutions which are favorable are 
retained (Van der Sloot et al., 2009). Another recent review article on random mutagenesis 
methods used in protein engineering/enzyme evolution also discussed different methods 
such as “error-prone” PCR mutagenesis, chemical mutagenesis, rolling circle error-prone 
PCR, saturation mutagenesis and novel methodologies (Labrou, 2010). The potential of “de 
novo enzyme engineering” method was also emphasized recently (Golynskiy & Seelig, 2010). 
De novo means that the enzymes are not based on a related parent protein regarding 
substrate or reaction mechanism. Obtaining de novo enzymes from scratch has been possible 
by i) in silico rational design; ii) utilizing the understanding of a reaction mechanism and the 
diversity of the immune system by means of catalytic antibodies; and iii) empirical search of 
large protein libraries by using mRNA display. mRNA display is a powerful new technique 
that can select de novo proteins from libraries that are several orders of magnitude larger 
than most other selection methods such as phage display and cell surface display. The 
proteins obtained by mRNA display method are covalently attached to the mRNA encoding 
them. Thus, each protein becomes directly amplifiable. The key feature of this method is the 
presence of the antibiotic puromycin that mimics a charged tRNA. Thus, puromycin is 
added into the growing polypeptide chain by the ribosome. The transcription of a synthetic 
DNA library into mRNA and its modification with puromycin is usually followed by in vitro 
translation, where a covalent link is made between each protein and the mRNA encoding 
that protein. This step is followed by reverse transcription of the library of mRNA-displayed 
proteins with a substrate-modified primer, and attachment of the substrate to the 
cDNA/RNA/protein complex. Proteins catalyzing the substrate reaction change their 
encoding cDNA with the product, and selected cDNA sequences are amplified by PCR and 
used for the next selection step (Golynskiy & Seelig, 2010). The future of protein engineering 
will definitely involve many new technologies and combinational use of existing methods. 
3. Protein engineering applications 
A variety of protein engineering applications have been reported in the literature. These 
applications range from biocatalysis for food and industry to environmental, medical and 
nanobiotechnology applications (as summarized in Table 2), and will be discussed in this 
section.  
3.1 Food and detergent industry applications 
Early reports on the importance of protein engineering methods to design new enzymes for 
enzyme biotechnological industries date back to 1993 (Wiseman, 1993). Particularly, the 
enzymes used in food industry were emphasized as an important group of enzymes, the 
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industrially important properties of which could be further improved by protein 
engineering. Those properties include thermostability, specificity and catalytic efficiency. 
Additionally, the design and production of new enzymes for food industry by using protein 
engineering was discussed to produce new food ingredients (James & Simpson, 1996). In a 
later review, new application areas of enzymes were discussed, resulting from significant 
developments in biotechnology, such as protein engineering and directed evolution. 
Successful combinations of rational protein engineering with directed evolution (Voigt et al., 
2000; Altamirano et al., 2000) have also been mentioned and it was emphasized that the 
combined use of rational design, directed evolution and the diversity of the nature would be 
much more powerful than the use of a single technique (Kirk et al., 2002). 
 
Application name Example reference(s) 
Food industry applications (James & Simpson, 1996), (Kirk et al., 2002), (Akoh et al., 
2008) 
Detergent industry 
applications (proteases) 
(Gupta et al., 2002) 
Environmental applications (Wiseman, 1993), (Cirino & Arnold, 2002), (Le Borgne & 
Quintero, 2003), (Ayala et al., 2008), (Cao et al., 2009) 
Medical applications (Buckel, 1996), (Filpula & McGuire, 1999), (Paques & 
Duchateau, 2007), (Nuttall & Walsh, 2008), (Liu et al., 2009), 
(Lam et al., 2003), (Zafir-Lavie et al., 2007), (Vazquez et al., 
2009), (Olafsen & Wu, 2010)  
Biopolymer production 
applications 
(Chow et al., 2008), (Rehm, 2010), (Banta et al., 2010) 
Nanobiotechnology 
applications 
(Hamada et al., 2004), (Banta et al., 2007) (Sarikaya et al., 
2003) (Tamerler et al., 2010) 
Applications with redox 
proteins and enzymes 
(Saab-Rincon & Valderrama, 2009), (Kumar, 2010) 
Applications with various 
industrially important 
enzymes 
(Martinkova & Kren, 2010), (Clapes et al., 2010), (Jordan & 
Wagschal, 2010), (Rao et al., 2009), (Marcaida et al., 2010). 
Other new applications (Lofblom et al., 2010), (Elleuche & Poggeler, 2010), (Klug, 
2010), 
(Guven et al., 2010),(Nagahara et al., 2009), (Henriques & 
Craik, 2010) 
Table 2. A general summary of selected protein engineering applications 
An important application area of protein engineering regarding food industry is the wheat 
gluten proteins. Their heterologous expression and protein engineering has been studied 
using a variety of expression systems, such as E.coli, yeasts or cultured insect cells. Wild-
type and mutant wheat gluten proteins were produced to compare them to each other for 
protein structure-function studies. Generally, E.coli expression systems were suggested as 
suitable systems for many applications, because of their availability, rapid and easy use, as 
well as high expression levels (Tamas & Shewry, 2006). Food industry makes use of a 
variety of food-processing enzymes, such as amylases and lipases, the properties of which 
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are improved using recombinant DNA technology and protein engineering. The deletion of 
native genes encoding extracellular proteases, for example, increased enzyme production 
yields of microbial hosts. In fungi, for example, the production of toxic secondary 
metabolites has been reduced to improve their productivity as enzyme-producing hosts 
(Olempska-Beer et al., 2006). 
Some large groups of enzymes like proteases, amylases and lipases are important for both 
food and detergent industries, as they have a broad range of industrial applications. 
Proteases, for example, are used in several applications of food industry regarding low 
allergenic infant formulas, milk clotting and flavors. They are also important for detergent 
industry for removing protein stains (Kirk et al., 2002). The improvement of proteases for 
industry to have, for example, high activity at alkaline pH and low temperatures, or 
improved stability at high temperatures is a challenge for protein engineering. Microbial 
protease production is industrially suitable because of low costs, high production yields, 
and easy genetic manipulation. Microbial protease genes have also been investigated for 
protein engineering of the enzymatic properties, clarifying the role of proteases in 
pathogenicity, as well as for overproduction purposes (Rao et al., 1998). There are some 
protein engineering applications to improve proteases: cold adaptation of a mesophilic 
subtilisin-like protease was performed using laboratory evolution (Wintrode et al., 2000); 
and DNA shuffling was applied to isolate new proteases with improved properties from an 
initial material of 26 subtilisin proteases (Ness et al., 1999). 
Among different proteases, bacterial alkaline proteases are a commercially important group. 
They are particularly important for detergent industry and commercial products include 
subtilisin Carlsberg, subtilisin BPN and Savinase. The use of protein engineering techniques 
resulted in improvement of their catalytic efficiency, stability against high temperatures, 
oxidation and changes in washing conditions. Site directed mutagenesis and/or random 
mutagenesis resulted in new alkaline proteases, such as Durazym, Maxapem and Purafect, 
whereas new subtilisin products with improved stability and specificity were also obtained 
by directed evolution. The recent “metagenomic” approaches to discover natural and 
molecular diversities were also suggested as new technologies to isolate new microbial 
sources with better alkaline protease activities (Gupta et al., 2002). Among many bacteria, 
Bacillus species play an important role in microbial commercial enzyme production. The fact 
that some Bacillus species are classified as GRAS (generally regarded as safe) organisms, and 
have the ability to produce and secrete high amounts of extracellular enzymes, makes them 
valuable hosts for industrial enzyme production. Classical mutation and selection 
techniques, as well as protein engineering methods resulted in high-efficiency production of 
new enzymes with improved properties (Schallmey et al., 2004).  
Amylases are also important for both food and detergent industries. In food industry, they 
are used for liquefaction and saccharification of starch, as well as in adjustment of flour and 
bread softness and volume in baking. The detergent industry makes use of amylases in 
removal of starch stains (Kirk et al., 2002). Recently, the production of “functional foods” is 
becoming increasingly important for food industry. Particularly, the production of 
industrial products and functional foods from cheap and renewable raw agricultural 
materials is desirable. Conversion of starch to bioethanol or to functional ingredients like 
fructose, wine, glucose and trehalose, for example, has been studied. Such a conversion 
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requires microbial fermentation in the presence of biocatalysts such as amylases to liquefy 
and saccharify starch. To improve the industrially important properties of amylases, such as 
high activity, high thermo- and pH-stability, high productivity, etc.; recombinant enzyme 
technology, protein engineering and enzyme immobilization have been used. In a recent 
review article, rice was given as a typical example for biocatalytical production of useful 
industrial products and functional foods from cheap agricultural raw materials and 
transgenic plants (Akoh et al., 2008).  
Another major group of enzymes utilized by food and detergent industries is constituted by 
lipases. They are used in many applications of food industry such as for the stability and 
conditioning of dough (as an in situ emulsifier), and in cheese flavor applications. Lipases 
are also crucial for the detergent industry, as they are used in removal of lipid stains (Kirk et 
al., 2002). As lipases are commonly used in food industrial applications, having 
toxicologically safe lipases is an important requirement of food industry. The commercial 
lipase isoform mixtures prepared from Candida rugosa meet this requirement. Obtaining 
pure and different C. rugosa lipase isoforms is possible by means of computer modelling of 
lipase isoforms, and protein engineering methods such as lid swapping and DNA shuffling 
(Akoh et al., 2004). A recent review on microbial lipases focused on non-aqueous microbial 
lipase catalysis and major factors affecting esterification/transesterification processes in 
organic media. Additionally, protein engineering, directed evolution, metagenomics and 
application of these strategies on lipase catalysis were discussed (Verma et al., 2008). 
Similarly, lipases from other organisms such as mammals and fishes were also reviewed 
(Kurtovic et al., 2009). 
3.2 Environmental applications 
Environmental applications of enzyme and protein engineering are also another important 
field. Early reports on enzyme and cell applications in industry and in environmental 
monitoring, such as environmental biosensors, date back to 1993 (Wiseman, 1993). One year 
later, recent genetic methods and strategies for designing microorganisms to eliminate 
environmental pollutants were discussed in detail. Those methods and strategies included 
gene expression regulation to provide high catalytic activity under environmental stress 
conditions, such as the presence of a toxic compound, rational changes introduced in 
regulatory proteins that control catabolic activities, creation of new metabolic routes and 
combinations thereof etc. (Timmis et al., 1994).  
In a later review in 2000, the importance of microbial strains and their enzymes in 
bioremediation and biotransformation applications was discussed, pointing out the 
utilization of modern strategies such as protein engineering or pathway engineering to 
improve microbial processes. Molybdenum hydroxylases, enzymes that catalyze the initial 
bacterial hydroxylation of a N-heteroaromatic compound, and ring-opening 2,4-
dioxygenases that play a role in the bacterial quinaldine degradation, were investigated in 
detail, to study and improve the enzymes involved in aerobic bacterial degradation of N-
heteroaromatic compounds (Fetzner, 2000). Protein engineering of oxygenases, an important 
group of enzymes with high selectivity and specificity, which enable the microbial 
utilization and biodegradation of organic, toxic compounds, was also discussed. The 
potential application of oxygenases in chemical synthesis and bioremediation was also 
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emphasized (Cirino & Arnold, 2002). Apart from oxygenases, other oxidative enzymes such 
as peroxidases and laccases are also important for the treatment of organic pollutants. These 
enzymes have broad substrate specificities and can catalyze the oxidation of a wide range of 
toxic organic compounds. Many organic pollutants such as phenols, azo dyes, 
organophosphorus pesticides and polycyclic aromatic hydrocarbons can be detoxified using 
enzymatic oxidation. However, there are some limitations of enzymatic treatment which 
should be overcome.  These include enzyme denaturation by the use of organic solvents 
used in enzymatic reactions, inhibition/stabilization of enzyme-substrate complexes, low 
reaction rates of laccases, toxicity of mediators, high costs and limited availability of the 
enzymes, etc. Chemical modification or protein engineering of oxidative enzymes to have 
robust enzymes with high activity was suggested (Torres et al., 2003). Another review article 
published in 2004 focused on the environmental applications with enzymes, such as the use 
of enzymes in waste management and pollution control. Protein engineering, rational 
enzyme design and recombinant DNA technology were mentioned as important research 
areas that would influence environmental enzyme applications. Utilization of new 
technologies such as gene shuffling, high throughput screening, and nanotechnology was 
suggested as future prospects of environmental enzyme applications (Ahuja et al., 2004).  
Petroleum biorefining is also an important environmental application area, where new 
biocatalysts are required. Protein engineering, isolation and study of new extremophilic 
microorganisms, genetic engineering developments are all promising advances to develop 
new biocatalysts for petroleum refining. Petroleum biorefining applications such as fuel 
biodesulfurization, denitrogenation of fuels, heavy metal removal, depolymerisation of 
asphaltenes, etc. were discussed (Le Borgne & Quintero, 2003).  
Microbial bioplastics, or polyhydroxyalkanoates (PHAs), are also an important research area 
in environmental biotechnology. They are storage polymers produced by many bacteria and 
archea, and their properties are similar to those of petroleum-derived plastics. PHAs are, 
however, biodegradable and thus, environment-friendly. Thus, microbial large-scale and 
low-cost production of PHAs is a challenge for biotechnologists. PHAs are deposited in cells 
as water-soluble, cytoplasmic granules of nano-size. Protein engineering of polyester 
synthases and phasins, the two proteins involved in PHA polyester formation, and 
structural issues, respectively, was used to understand the genetics and biochemistry of 
PHA granule self-assembly. This information would also be used for medical applications 
involving biocompatible and biodegradable biomaterials (Rehm, 2006). The biogenesis of 
microbial polyhydroxyalkanoate granules, and protein engineering of polyester synthases 
and phasins to functionalize the polyester particle surface allowed microbial and 
biocatalytic production of particles with controlled size, polyester care composition and 
surface functionality. This would allow a platform technology for the production of tailor-
made bioparticles, particularly for medical applications (Rehm, 2007).  
In a recent review, microbial surface display applications for environmental bioremediation 
and biofuels production were discussed. Yeast and bacterial cell systems where proteins or 
peptides are expected on the cell exterior were reported to be used as biocatalysts, 
biosorbents and biostimulants (Wu et al., 2008).   
Another important environmental application of protein engineering involves fungal 
enzymes. Particularly peroxidases isolated from fungi can transform xenobiotics and many 
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pollutants. For the development of applications, the enzyme stability and availability need 
to be improved. Thus, many protein engineering strategies were identified such as 
improvement of hydrogen peroxide stability, increasing the redox potential to broaden the 
substrate range, heterologous expression and industrial production development (Ayala et 
al., 2008).  
In recent reviews on environmental applications of protein engineering, recent ‘omics’ 
technologies have also been discussed. Metagenomic libraries, which identify and analyze 
genetic resources of complex microbial communities were suggested to help identify 
microbial enzymatic diversity, with implications in medicine, environmental issues, 
agriculture etc. Thus, contributions in renewable energy sources, decrease in pollutant 
burdens and process energies were expected with metagenomics applications in the future 
(Ferrer et al., 2009). Similarly, in a review on biodegradation of aromatic compounds such as 
benzene, toluene, ethylbenzene and xylene, the importance of metabolic engineering, 
protein engineering, and “omics” technologies were emphasized (Cao et al., 2009).  
3.3 Medical applications 
Medical applications of protein engineering are also diverse. The use of protein engineering 
for cancer treatment studies is a major area of interest. Pretargeted radioimmunotherapy has 
been discussed as a potential cancer treatment. By pretargeting, radiation toxicity is 
minimized by separating the rapidly cleared radionuclide and the long-circulating antibody.  
Advances in protein engineering and recombinant DNA technology were expected to 
increase the use of pretargeted radioimmunotherapy (Lam et al., 2003). The use of novel 
antibodies as anticancer agents is also an important field of application, where the ability of 
antibodies to select antigens specifically and with high affinity is exploited, and protein 
engineering methods are used to modify antibodies to target cancer cells for clinical 
applications (Zafir-Lavie et al., 2007). Recently, the term “modular protein engineering” has 
been introduced for emerging cancer therapies. Treatment strategies based on targeted 
nanoconjugates to be specifically directed against target cells are becoming increasingly 
important. Additionally, multifunctional and smart drug vehicles can be produced at the 
nanoscale, by protein engineering. These strategies could be combined to identify and select 
targets for protein-based drug delivery (Vazquez et al., 2009). 
Protein engineering applications for therapeutic protein production is an important area, 
particularly for medicine. In 1996, recombinant protein production for therapeutic purposes 
was reviewed. It was stated that protein engineering resulted in a second generation of 
therapeutic protein products with application-specific properties obtained by mutation, 
deletion of fusion. The third generation of such products were mentioned as “gene therapy” 
protein products to be produced by the patients, upon gene transfer (Buckel, 1996). Other 
studies on therapeutic protein production include single-chain Fv designs for protein, cell 
and gene therapy (Filpula & McGuire, 1999). DNA shuffling and recursive genetic 
recombination studies to improve therapeutic proteins (Kurtzman et al., 2001); development 
of secreted proteins such as insulin, interferon, erythropoietin as biotherapeutics agents 
(Bonin-Debs et al., 2004), combinatorial protein biochemistry for therapeutics and 
proteomics (Lowe & Jermutus, 2004), meganucleases and DNA double-strand break-
induced recombination for gene therapy (Paques & Duchateau, 2007), the use of protein 
cationization techniques for future drug discovery and development (Futami et al., 2007), 
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protein display scaffolds for protein engineering of new therapeutics (Nuttall & Walsh, 
2008), and polymer-based therapeutics for drug delivery and tissue regeneration (Liu et al., 
2009).  
Protein engineering applications with antibodies are also diverse. Owing to advances in 
recombinant DNA technology, “antibody engineering” is possible. Improvements such as 
minimal recognition units and antigenized antibodies were described. Combinational 
approaches such as bacteriophage display libraries have been introduced as a strong 
alternative to hybridoma technology for antibody production with desired antigen binding 
characteristics (Sandhu, 1992). Studies on genetic manipulation of mouse monoclonals for 
producing humanized antibodies and bacteriophage display libraries for Ig repertoires have 
been reported (Zaccolo & Malavasi, 1993). Phage display has become a powerful technique 
in protein engineering, immunology, oncology, etc. Phage display of antibody fragments, 
particularly the production of artificial epitopes by phage antibodies is an important 
application (Pini & Bracci, 2000).  “Antibody modeling” studies to engineer antibody-like 
molecules and increase their stability and specificity are also common, particularly for 
humanization of antibodies of animal origin (Morea et al., 2000). Recently, the use of 
antibodies as vectors for molecular imaging has become popular. Pharmacokinetic 
properties of antibodies have been improved by protein engineering and antibody variants 
of different size and antigen binding sites have been produced for the ultimate use as 
imaging probes specific to target tissues. A variety of examples include antibody fragments 
which have been conjugated to bioluminescence, fluorescence, quantum dots for optical 
imaging, as well as iron oxide nanoparticles for magnetic resonance imaging. It is obvious 
that molecular imaging tools based on antibodies will find more applications in the future 
regarding diagnosis and treatment of cancer and other complex diseases (Olafsen & Wu, 
2010).  
3.4 Applications for biopolymer production 
Protein engineering applications for biopolymer production are also promising. Particularly, 
peptides are becoming increasingly important as biomaterials because of their specific 
physical, chemical and biological properties.  Protein engineering and macromolecular self-
assembly are utilized to produce peptide-based biomaterials, such as elastin-like 
polypeptides, silk-like polymers, etc. (Chow et al., 2008). Similarly, biosynthesis, 
modification and applications of bacterial polymers have also been discussed recently 
(Rehm, 2010). 
The ability of protein engineering to create and improve protein domains can be utilized for 
producing new biomaterials for medical and engineering applications. One such example is 
the use of protein engineering to make new protein and peptide domains which enable 
advanced functional hydrogel formation. These domains include leucine zipper coiled-coil 
domains, the EF-band domains and elastin-like polypeptides (Banta et al., 2010). 
3.5 Nanobiotechnology applications 
Nanobiotechnology applications of protein engineering are becoming increasingly 
important. The synthesis and assembly of nanotechnological systems into functional 
structures and devices has been difficult and limiting their potential applications for a long 
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time. However, when biomaterials are investigated, it can be realized that they are highly 
organized from molecular to the nano- and macroscales, hierarchically. Biological 
macromolecules, such as proteins, carbohydrates and lipids are used in the synthesis of 
biological tissues in aqueous environments and mild physiological conditions, where this 
biosynthetic process is under genetic regulation. Particularly proteins are crucial elements of 
biological systems, based on their roles in transport, regulation of tissue formation, physical 
performance and biological functions. Thus, they are suitable components for controlled 
synthesis and assembly of nanotechnological systems. Combinatorial biology methods 
commonly applied in protein engineering studies, such as phage display and bacterial cell 
surface display technologies, are also used to select polypeptide sequences which selectively 
bind to inorganic compound surfaces, for ultimate applications of nanobiotechnology. 
Biopanning procedures that involve washing cycles of the phages or the cells to remove 
nonbinders from the surface reveal individual clones that strongly bind to a given inorganic 
surface. Those clones are then sequenced to identify the amino acid sequences of the 
polypeptides which bind strongly to the inorganic target compound surface, such as (noble) 
metals, semiconducting oxides and other important compounds for nanotechnology. The so-
called “genetically engineered proteins for inorganics” (GEPIs) were suggested as important 
tools for the self-assembly of molecular systems in nanobiotechnology (Sarikaya et al., 2003). 
Since then, many genetically engineered peptides have been selected that specifically bind a 
variety of inorganic materials such as platinum, gold, and quartz; and their binding 
characteristics were investigated (Seker et al., 2009; Oren et al., 2010). Combining 
experimental approaches with computational tools allows engineering of the peptide 
binding and assembly characteristics. Thus, higher generation function-specific peptides can 
be obtained for applications in tissue engineering, therapeutics, and nanotechnology where 
inorganic, organic and biological materials are used (Tamerler et al., 2010). Engineering 
protein and peptide building blocks to be used as molecular motors, transducers, 
biosensors, and structural elements of nanodevices, and the importance of proteins and 
peptides for the development of biocompatible nanomaterials, as well as the impact of 
computational techniques in this field have been well recognized (Banta et al., 2007).  
Another interesting nanotechnology application is the use of amyloid fibrils as structural 
templates for nanowire construction. This application is based on the fact that some proteins 
form well-ordered fibrillar aggregates that are called amyloid fibrils. As the self-
organization and assembly of small molecules are crucial for nanotechnology, the self-
association of well-ordered growth fibrils through noncovalent bonds under controlled 
conditions was suggested to have a high potential to be used for nanobiotechnology. The 
use of amyloid fibrils as structural templates for nanowire construction was explained as a 
typical example of potential applications (Hamada et al., 2004). 
3.6 Applications with redox proteins and enzymes 
Improvement of redox proteins and enzymes by protein engineering is also an important 
application field. Such proteins and enzymes can be modified to be used in nanodevices for 
biosensing, as well as for nanobiotechnology applications (Gilardi & Fantuzzi, 2001). The 
electrochemistry of redox proteins particularly draws attention for applications in biofuel 
cells, chemical synthesis and biosensors. Thus, protein engineering applications using 
rational design, directed evolution and combination thereof are found for bioelectrocatalysis 
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(Wong & Schwaneberg, 2003). A recent review on protein engineering of redox-active 
enzymes pointed out two emerging areas of protein engineering of redox-active enzymes: 
novel nucleic acid-based catalyst construction, and intra-molecular electron transfer 
network remodelling (Saab-Rincon & Valderrama, 2009). A variety of studies focused on 
cytochrome P450 superfamily of enzymes, such as heme monooxygenases which are 
involved in biosynthesis and biodegradation of metabolic compounds and in the oxidation 
of xenobiotics. Thus, protein engineering of P450 enzymes for degradation of xenobiotics is 
a biotechnological challenge (Wong et al., 1997).  Additionally, the fact that heterologous 
expression of P450s in bacteria resulted in blue pigment formation required detailed studies 
of intermediary metabolism, toxicology, further protein engineering studies and suggested 
potential applications in dye industry (Gillam & Guengerich, 2001). More recently, review 
articles were published on cytochrome P450 monooxygenases (Urlacher & Eiben, 2006) and 
protein engineering of cytochrome P450 biocatalysts for medical, biotechnological and 
bioremediation applications (Kumar, 2010). 
3.7 Applications with various industrially important enzymes 
Protein engineering applications with a variety of industrially important enzymes can be 
found in the literature. These include nitrilases (Martinkova & Kren, 2010), aldolases (Clapes 
et al., 2010), microbial beta-D-xylosidases (Jordan & Wagschal, 2010) etc. Nitrilases are 
important enzymes for biotransformation, but the enzymatic reactions require improvement 
for higher industrial process efficiencies. For this purpose, new enzymes were screened 
from new isolates, medium and protein engineering methods were applied (Martinkova & 
Kren, 2010). Aldolases are also important enzymes for stereoselective synthesis reactions 
regarding carbon-carbon bond formation in synthetic organic chemistry. Protein 
engineering or screening methods improved aldolases for such synthesis reactions. De novo 
computational design of aldolases, aldolase ribozymes etc. are promising applications 
(Clapes et al., 2010). Microbial beta-D-xylosidases are also an industrially important group of 
enzymes, particularly for baking industry, animal feeding, D-xylose production for xylitol 
manufacturing and deinking of recycled paper. As they catalyse hydrolysis of non-reducing 
end xylose residues from xylooligosaccharides, they could be used for the hydrolysis of 
lignocellulosic biomass in biofuel fermentations to produce ethanol and butanol. Thus, 
improving the catalytic efficiency of beta-D-xylosidases is crucial for many industrial 
applications (Jordan & Wagschal, 2010). As the use of organic solvents is industrially 
suitable for enzymatic reactions, but has adverse effects on enzyme activity and/or stability, 
protein engineering of organic solvent tolerant enzymes (Gupta, 1992; Doukyu & Ogino, 
2010) has become an important research area. Screening organic solvent-tolerant bacteria or 
extremophiles has been preferred to isolate and improve naturally solvent-stable enzymes 
(Gupta & Khare, 2009; Doukyu & Ogino, 2010). Other protein engineering examples with 
industrially and/or pharmacologically important enzymes include studies on cholesterol 
oxidase (Pollegioni et al., 2009), cyclodextrin glucanotransferases (Leemhuis et al., 2010), 
human butyrylcholinesterase (Masson et al., 2009), microbial glucoamylases (Kumar & 
Satyanarayana, 2009), lipases of different origins (Akoh et al., 2004; Verma et al., 2008; 
Kurtovic et al., 2009), phospholipases (Song et al., 2005; De Maria et al., 2007; Simockova & 
Griac, 2009) and phytases (Rao et al., 2009). Studies on extremozymes, enzymes isolated 
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from extremophilic species, revealed their different structural and functional characteristics 
which could be exploited for biotechnological applications and improved further by protein 
engineering (Bjarnason et al., 1993; Hough & Danson, 1999; Georlette et al., 2004). Homing 
endonucleases are another important group of enzymes with application potential in gene 
therapy of monogenic diseases. They are double-stranded DNases with extremely rare 
recognition sites, and are used as templates for engineering genetic tools to cleave DNA 
sequences different from the wild-type targets (Marcaida et al., 2010).  
3.8 Other new applications 
Recently, novel types of proteins have been developed, using combinatorial protein 
engineering techniques. These binding proteins of non-Ig origin are called “affibody binding 
proteins”. With their high affinity, these proteins have been used in many different 
applications such as diagnostics, bioseparation, functional inhibition, viral targeting, and in 
vivo tumor imaging or therapy (Nygren, 2008). More recently, comprehensive reviews on 
engineered affinity proteins (Gronwall & Stahl, 2009), and affibody molecules (Lofblom et 
al., 2010) were published, where their therapeutic, diagnostic and biotechnological 
applications were discussed in detail.  
Inteins are protein splicing elements that are involved in a variety of applications such as 
protein purification, protein semisynthesis, in vivo and in vitro protein modifications. The 
use of intein tags for protein purification in plants with high protein production could 
potentially enable industrial production of pharmaceutically important proteins (Evans et 
al., 2005). The proteolytic cleavage and ligation activities of inteins have been understood, 
which resulted in novel intein applications in protein engineering, enzymology, microarray 
production, target detection and transgene activation in plants. The conversion of inteins 
into molecular switches was introduced by intein-mediated protein attachment to solid 
supports for microarray and western blot studies and by linking nucleic acids to proteins 
and controlled splicing (Perler, 2005). Recent intein-mediated protein engineering 
applications like protein purification, ligation, cyclization and selenoprotein production 
have been discussed in detail lately (Elleuche & Poggeler, 2010).  
“Insertional protein engineering” applications are also becoming important, particularly for 
biosensor studies. The applications of insertional protein engineering for analytical 
molecular sensing have been reviewed by Ferraz and coworkers (Ferraz et al., 2006). 
“Zinc finger protein engineering” is another approach that has been used in gene regulation 
applications. The zinc finger design and principle is used to design DNA binding proteins to 
control gene expression. Examples include a three-finger protein to block the expression of 
an oncogene that was transformed into a mouse cell line. Fusion of zinc finger peptides to 
repression or activation domains allows selective gene switching off and on (Klug, 2010).  
Applications of protein engineering in enzymatic biofuel cell design is also becoming 
increasingly important. Particularly, obtaining biofuels from lignocellulosic resources is a 
challenge, as the enzyme hydrolysis efficiency of lignocellulose is low which increases the 
costs of biofuels. Thus, protein engineering methods have been used to improve the 
performance of lignocellulose-degrading enzymes, and biofuels-synthesizing enzymes (Wen 
et al., 2009). Protein engineering is also applied to obtain an efficient electrical 
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communication between biocatalyst(s) and the electrode by rational design and directed 
evolution, within the frame of biocatalyst engineering (Guven et al., 2010). 
“Virus engineering” is another emerging field, where the virus particles are modified by 
protein engineering. Viruses have many promising applications in medicine, biotechnology 
and nanotechnology. They could be used as new vaccines, gene therapy and targeted drug 
delivery vectors, molecular imaging agents and as building blocks for electronic 
nanodevices or nanomaterials construction. Thus, the improvement of the physical stability 
of viral particles is crucial for efficient applications with them. Protein engineering methods 
are employed to improve physical stability of viral particles (Mateu, 2011). 
“Protein cysteine modifications” are also important protein engineering applications. As 
cysteine modifications in proteins cause diversities in protein functions, cysteine thiol 
chemistry has been applied for in vitro glycoprotein synthesis. This method could be 
potentially used for development of new protein-based drugs, improving their half-life, 
reducing their toxicity and preventing multidrug resistance development (Nagahara et al., 
2009).  
Cyclotides are important proteins that have recently been popular for protein engineering 
applications. They are plant proteins made up from small disulfide-rich peptides and are 
exceptionally stable to thermal, chemical or enzymatic degradation. This property of 
cyclotides makes them valuable molecular templates for many protein engineering and drug 
design applications (Craik et al., 2007; Daly et al., 2009; Henriques & Craik, 2010). 
4. Conclusion 
The modification of natural enzymes and proteins by protein engineering is an increasingly 
important scientific field. The well-known methods of rational design and directed 
evolution, as well as new techniques will enable efficient and easy modification of proteins.  
New technologies such as computational design, catalytic antibodies and mRNA display 
would be crucial for de novo engineering of enzymes and also for new areas of protein 
engineering. 
Protein engineering applications cover a broad range, including biocatalysis for food and 
industry, as well as medical, environmental and nanobiotechnological applications. With 
advances in recombinant DNA technology tools, “omics” technologies and high-throughput 
screening facilities, improved methods for protein engineering will be available, which 
would enable easy modification or improvement of more proteins/enzymes for further 
specific applications. 
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